Cargando…

Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States

BACKGROUND AND OBJECTIVES: Persons with epilepsy, especially those with drug resistant epilepsy (DRE), may benefit from inpatient services such as admission to the epilepsy monitoring unit (EMU) and epilepsy surgery. The COVID-19 pandemic caused reductions in these services within the US during 2020...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahrens, Stephanie M., Ostendorf, Adam P., Lado, Fred Alexander, Arnold, Susan T., Bai, Shasha, Bensalem-Owen, Meriem K., Chapman, Kevin E., Clarke, Dave F., Eisner, Mariah, Fountain, Nathan B., Gray, Johanna M., Gunduz, Muhammed Talha, Hopp, Jennifer L., Riker, Ellen, Schuele, Stephan U., Small, Barbara, Herman, Susan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141627/
https://www.ncbi.nlm.nih.gov/pubmed/35292559
http://dx.doi.org/10.1212/WNL.0000000000200285
_version_ 1784715390336630784
author Ahrens, Stephanie M.
Ostendorf, Adam P.
Lado, Fred Alexander
Arnold, Susan T.
Bai, Shasha
Bensalem-Owen, Meriem K.
Chapman, Kevin E.
Clarke, Dave F.
Eisner, Mariah
Fountain, Nathan B.
Gray, Johanna M.
Gunduz, Muhammed Talha
Hopp, Jennifer L.
Riker, Ellen
Schuele, Stephan U.
Small, Barbara
Herman, Susan T.
author_facet Ahrens, Stephanie M.
Ostendorf, Adam P.
Lado, Fred Alexander
Arnold, Susan T.
Bai, Shasha
Bensalem-Owen, Meriem K.
Chapman, Kevin E.
Clarke, Dave F.
Eisner, Mariah
Fountain, Nathan B.
Gray, Johanna M.
Gunduz, Muhammed Talha
Hopp, Jennifer L.
Riker, Ellen
Schuele, Stephan U.
Small, Barbara
Herman, Susan T.
author_sort Ahrens, Stephanie M.
collection PubMed
description BACKGROUND AND OBJECTIVES: Persons with epilepsy, especially those with drug resistant epilepsy (DRE), may benefit from inpatient services such as admission to the epilepsy monitoring unit (EMU) and epilepsy surgery. The COVID-19 pandemic caused reductions in these services within the US during 2020. This article highlights changes in resources, admissions, and procedures among epilepsy centers accredited by the National Association of Epilepsy Centers (NAEC). METHODS: We compared data reported in 2019, prior to the COVID-19 pandemic, and 2020 from all 260 level 3 and level 4 NAEC accredited epilepsy centers. Data were described using frequency for categorical variables and median for continuous variables and were analyzed by center level, center population category, and geographical location. Qualitative responses from center directors to questions regarding the impact from COVID-19 were summarized utilizing thematic analysis. Responses from the NAEC center annual reports as well as a supplemental COVID-19 survey were included. RESULTS: EMU admissions declined 23% (-21,515) in 2020, with largest median reductions in level 3 centers [-55 admissions (-44%)] and adult centers [-57 admissions (-39%)]. The drop in admissions was more substantial in the East North Central, East South Central, Mid Atlantic, and New England US Census divisions. Survey respondents attributed reduced admissions to re-assigning EMU beds, restrictions on elective admissions, reduced staffing, and patient reluctance for elective admission. Treatment surgeries declined by 371 cases (5.7%), with the largest reduction occurring in VNS implantations [-486 cases (-19%)] and temporal lobectomies [-227 cases (-16%)]. All other procedure volumes increased, including a 35% (54 cases) increase in corpus callosotomies. DISCUSSION: In the US, access to care for persons with epilepsy declined during the COVID-19 pandemic in 2020. Adult patients, those relying on level 3 centers for care, and many persons in the eastern half of the US were most affected.
format Online
Article
Text
id pubmed-9141627
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-91416272022-05-31 Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States Ahrens, Stephanie M. Ostendorf, Adam P. Lado, Fred Alexander Arnold, Susan T. Bai, Shasha Bensalem-Owen, Meriem K. Chapman, Kevin E. Clarke, Dave F. Eisner, Mariah Fountain, Nathan B. Gray, Johanna M. Gunduz, Muhammed Talha Hopp, Jennifer L. Riker, Ellen Schuele, Stephan U. Small, Barbara Herman, Susan T. Neurology Research Article BACKGROUND AND OBJECTIVES: Persons with epilepsy, especially those with drug resistant epilepsy (DRE), may benefit from inpatient services such as admission to the epilepsy monitoring unit (EMU) and epilepsy surgery. The COVID-19 pandemic caused reductions in these services within the US during 2020. This article highlights changes in resources, admissions, and procedures among epilepsy centers accredited by the National Association of Epilepsy Centers (NAEC). METHODS: We compared data reported in 2019, prior to the COVID-19 pandemic, and 2020 from all 260 level 3 and level 4 NAEC accredited epilepsy centers. Data were described using frequency for categorical variables and median for continuous variables and were analyzed by center level, center population category, and geographical location. Qualitative responses from center directors to questions regarding the impact from COVID-19 were summarized utilizing thematic analysis. Responses from the NAEC center annual reports as well as a supplemental COVID-19 survey were included. RESULTS: EMU admissions declined 23% (-21,515) in 2020, with largest median reductions in level 3 centers [-55 admissions (-44%)] and adult centers [-57 admissions (-39%)]. The drop in admissions was more substantial in the East North Central, East South Central, Mid Atlantic, and New England US Census divisions. Survey respondents attributed reduced admissions to re-assigning EMU beds, restrictions on elective admissions, reduced staffing, and patient reluctance for elective admission. Treatment surgeries declined by 371 cases (5.7%), with the largest reduction occurring in VNS implantations [-486 cases (-19%)] and temporal lobectomies [-227 cases (-16%)]. All other procedure volumes increased, including a 35% (54 cases) increase in corpus callosotomies. DISCUSSION: In the US, access to care for persons with epilepsy declined during the COVID-19 pandemic in 2020. Adult patients, those relying on level 3 centers for care, and many persons in the eastern half of the US were most affected. Lippincott Williams & Wilkins 2022-05-10 /pmc/articles/PMC9141627/ /pubmed/35292559 http://dx.doi.org/10.1212/WNL.0000000000200285 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research Article
Ahrens, Stephanie M.
Ostendorf, Adam P.
Lado, Fred Alexander
Arnold, Susan T.
Bai, Shasha
Bensalem-Owen, Meriem K.
Chapman, Kevin E.
Clarke, Dave F.
Eisner, Mariah
Fountain, Nathan B.
Gray, Johanna M.
Gunduz, Muhammed Talha
Hopp, Jennifer L.
Riker, Ellen
Schuele, Stephan U.
Small, Barbara
Herman, Susan T.
Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
title Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
title_full Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
title_fullStr Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
title_full_unstemmed Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
title_short Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
title_sort impact of the covid-19 pandemic on epilepsy center practice in the united states
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141627/
https://www.ncbi.nlm.nih.gov/pubmed/35292559
http://dx.doi.org/10.1212/WNL.0000000000200285
work_keys_str_mv AT ahrensstephaniem impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT ostendorfadamp impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT ladofredalexander impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT arnoldsusant impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT baishasha impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT bensalemowenmeriemk impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT chapmankevine impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT clarkedavef impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT eisnermariah impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT fountainnathanb impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT grayjohannam impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT gunduzmuhammedtalha impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT hoppjenniferl impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT rikerellen impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT schuelestephanu impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT smallbarbara impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates
AT hermansusant impactofthecovid19pandemiconepilepsycenterpracticeintheunitedstates